{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-131410","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2021-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.045129+00:00","generated_at":"2026-06-28T16:09:15.864564+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"iRadimed Q3 revenue up 42% to $10.9M; raises full-year guidance","bullets":["Q3 2021 revenue $10.9M (+42% YoY); GAAP diluted EPS $0.20, non-GAAP $0.23.","Full-year 2021 guidance raised: revenue $41.4-41.6M, GAAP EPS $0.60-0.61, non-GAAP $0.70-0.71.","Gross profit margin improved to 77.1% from 74.6% in Q3 2020; domestic sales 79.5% of revenue.","Nine-month operating cash flow $7.9M vs $3.3M; free cash flow $7.5M vs $3.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-131410","json":"https://secwatch.observer/filing/0001104659-21-131410.json","markdown":"https://secwatch.observer/filing/0001104659-21-131410.md","text":"https://secwatch.observer/filing/0001104659-21-131410.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000110465921131410/0001104659-21-131410-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000110465921131410/tm2131304d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:09:15.864564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}